SC 13D Filing

Company

Theriva Biologics, Inc.

Filed

April 10, 1997

Accession Number

0000895813-97-000094

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →